Silence Therapeutics PLC in brief
Silence Therapeutics PLC is a listed company in the Biotechnology industry, based in the UK. It was founded in 1994. Its last known market value was $189 M (July 2023); there is no current figure. In the year to Dec 2021 it had sales of $14 M and a net loss of $46 M. It employs about 88 people. Its shares trade under the symbol XRP2.F (Frankfurt).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Silence Therapeutics PLC
Silence Therapeutics (Nasdaq: SLN) is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.
From Wikipedia: read the full article · text available under CC BY-SA 4.0
Silence Therapeutics PLC timeline
- 1994
- 🏁· approximateFounded
- 2015
- •Legal Entity Identifier issuedLEI 213800SSURRJBX85SQ91 registered.
Events of Silence Therapeutics PLC from Wikidata and the GLEIF LEI register. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in UK: #381 (Jan 2020) · #495 (Jan 2021) · #538 (Jan 2022) · #439 (Dec 2022) · #708 (Jul 2023)
Key ratios
- P/E ratio
- n/m (loss)
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- -328.6%
- Operating margin
- -650.6%
- Return on equity
- -511.1%
- Liabilities / assets
- 90.3%
- Revenue per employee
- $159 K
- Profit per employee
- $-523 K
Annual results
- Revenue
- $14 M
- Operating income
- $-91 M
- Net income
- $-46 M
Dec-2021 ending year
Balance sheet
- Total assets
- $113 M
- Total liabilities
- $102 M
- Total equity
- $9 M
Dec-2021 ending year
Top 92 institutional investors in Silence Therapeutics PLC#
| # | Institution | Shares held | Change (shares) | Value | Filed |
|---|---|---|---|---|---|
| 1 | FMR LLC | 4,710,812 | New | $51 M | Nov 10, 2026 |
| 2 | Siren, L.L.C. | 2,887,867 | -423,571 (-12.79%) | $32 M | Nov 12, 2026 |
| 3 | Citadel Advisors LLC | 2,825,601 | +1,495,976 (+112.51%) | $31 M | Nov 16, 2026 |
| 4 | Redmile Group, LLC | 2,460,894 | +296,117 (+13.68%) | $27 M | Nov 16, 2026 |
| 5 | Tetragon Partners GP Ltd | 2,436,051 | +1,671,795 (+218.75%) | $27 M | Nov 16, 2026 |
| 6 | Soleus Capital Management, L.P. | 2,385,700 | +1,755,700 (+278.68%) | $26 M | Nov 16, 2026 |
| 7 | Balyasny Asset Management L.P. | 2,254,235 | +1,643,255 (+268.95%) | $25 M | Nov 16, 2026 |
| 8 | Squadron Capital Management LLC | 2,085,000 | New | $23 M | Nov 16, 2026 |
| 9 | TCG Crossover Management, LLC | 1,819,035 | -1,214,525 (-40.04%) | $20 M | Nov 16, 2026 |
| 10 | Morgan Stanley | 1,761,030 | +1,357,858 (+336.79%) | $19 M | Nov 13, 2026 |
| 11 | Nextech Invest Ltd. | 1,693,140 | +740,740 (+77.78%) | $19 M | Nov 16, 2026 |
| 12 | Millennium Management LLC | 1,453,540 | +544,261 (+59.86%) | $16 M | Nov 16, 2026 |
| 13 | BNP Paribas Financial Markets | 1,173,108 | +1,014,158 (+638.04%) | $13 M | Nov 12, 2026 |
| 14 | Nantahala Capital Management, LLC | 1,162,384 | -1,531,078 (-56.84%) | $13 M | Nov 13, 2026 |
| 15 | Qube Research & Technologies Ltd | 1,058,988 | +895,043 (+545.94%) | $12 M | Nov 13, 2026 |
| 16 | Ameriprise Financial Inc | 1,038,369 | +668,317 (+180.60%) | $11 M | Nov 16, 2026 |
| 17 | Ikarian Capital, LLC | 821,790 | -8,994 (-1.08%) | $9 M | Nov 16, 2026 |
| 18 | Susquehanna International Group, LLP | 820,638 | +636,119 (+344.74%) | $9 M | Nov 16, 2026 |
| 19 | Persistent Asset Partners Ltd | 781,965 | +766,795 (+5054.68%) | $9 M | Nov 13, 2026 |
| 20 | Montanova Capital, LLC | 740,740 | New | $8 M | Nov 16, 2026 |
| 21 | RTW Investments, LP | 700,000 | New | $8 M | Nov 16, 2026 |
| 22 | KVP Capital Advisors, LP | 684,123 | New | $7 M | Nov 16, 2026 |
| 23 | Two Sigma Investments, LP | 679,702 | +558,698 (+461.72%) | $7 M | Nov 16, 2026 |
| 24 | ADAR1 Capital Management, LLC | 629,654 | +291,281 (+86.08%) | $7 M | Nov 16, 2026 |
| 25 | UBS Group AG | 609,678 | +366,526 (+150.74%) | $7 M | Nov 10, 2026 |
Show all 92: investors 26 to 92
| # | Institution | Shares held | Change (shares) | Value | Filed |
|---|---|---|---|---|---|
| 26 | Caption Management, LLC | 518,674 | +356,198 (+219.23%) | $6 M | Nov 16, 2026 |
| 27 | Toronto Dominion Bank | 486,189 | New | $5 M | Nov 16, 2026 |
| 28 | 5AM Venture Management, LLC | 476,200 | 0 (0.00%) | $5 M | Nov 16, 2026 |
| 29 | Goldman Sachs Group Inc | 462,831 | +306,902 (+196.82%) | $5 M | Nov 16, 2026 |
| 30 | Affinity Asset Advisors, LLC | 450,000 | New | $5 M | Nov 13, 2026 |
| 31 | Lombard Odier Asset Management (Europe) Ltd | 423,857 | New | $5 M | Nov 16, 2026 |
| 32 | Acuta Capital Partners, LLC | 393,583 | New | $4 M | Nov 16, 2026 |
| 33 | Alyeska Investment Group, L.P. | 364,920 | New | $4 M | Nov 16, 2026 |
| 34 | Seven Fleet Capital Management LP | 350,000 | +289,893 (+482.29%) | $4 M | Nov 16, 2026 |
| 35 | BlackRock, Inc. | 330,529 | +110,612 (+50.30%) | $4 M | Nov 13, 2026 |
| 36 | Woodline Partners LP | 300,000 | New | $3 M | Nov 16, 2026 |
| 37 | Fred Alger Management, LLC | 250,142 | +73,142 (+41.32%) | $3 M | Nov 16, 2026 |
| 38 | Seven Grand Managers, LLC | 250,000 | New | $3 M | Nov 16, 2026 |
| 39 | Fortress Investment Group LLC | 230,000 | New | $3 M | Nov 16, 2026 |
| 40 | Cantor Fitzgerald, L. P. | 217,990 | New | $2 M | Nov 16, 2026 |
| 41 | Sofinnova Investments, Inc. | 211,802 | New | $2 M | Nov 16, 2026 |
| 42 | Aberdeen Group plc | 205,865 | New | $2 M | Nov 10, 2026 |
| 43 | Bank Of Montreal /can/ | 201,176 | -558 (-0.28%) | $2 M | Nov 9, 2026 |
| 44 | Boothbay Fund Management, LLC | 200,568 | +2,221 (+1.12%) | $2 M | Nov 16, 2026 |
| 45 | Nomura Holdings Inc | 199,546 | New | $2 M | Nov 16, 2026 |
| 46 | Barclays PLC | 195,958 | +192,540 (+5633.12%) | $2 M | Nov 6, 2026 |
| 47 | Jane Street Group, LLC | 192,595 | -176,556 (-47.83%) | $2 M | Nov 12, 2026 |
| 48 | Ishara Investments LP | 160,000 | +104,650 (+189.07%) | $2 M | Nov 16, 2026 |
| 49 | Renaissance Technologies LLC | 152,200 | +135,270 (+799.00%) | $2 M | Nov 12, 2026 |
| 50 | Squarepoint Ops LLC | 147,577 | +31,659 (+27.31%) | $2 M | Nov 9, 2026 |
| 51 | Diadema Partners LP | 135,000 | New | $1 M | Nov 16, 2026 |
| 52 | Adage Capital Partners GP, L.L.C. | 130,000 | New | $1 M | Nov 16, 2026 |
| 53 | Quadrature Capital Ltd | 101,242 | -16,887 (-14.30%) | $1 M | Nov 13, 2026 |
| 54 | M28 Capital Management LP | 101,203 | 0 (0.00%) | $1 M | Nov 13, 2026 |
| 55 | Soros Fund Management LLC | 100,000 | New | $1 M | Nov 13, 2026 |
| 56 | Burkehill Global Management, LP | 100,000 | New | $1 M | Nov 16, 2026 |
| 57 | HSBC Holdings PLC | 76,201 | -46,633 (-37.96%) | $1 M | Nov 16, 2026 |
| 58 | Marshall Wace, LLP | 60,322 | -11,717 (-16.26%) | $1 M | Nov 13, 2026 |
| 59 | Tudor Investment Corp Et Al | 44,252 | New | $0 M | Nov 16, 2026 |
| 60 | Royal Bank Of Canada | 41,962 | +41,936 (+161292.31%) | $0 M | Nov 16, 2026 |
| 61 | Point72 Asset Management, L.P. | 40,192 | New | $0 M | Nov 16, 2026 |
| 62 | Y-Intercept (Hong Kong) Ltd | 40,107 | New | $0 M | Oct 16, 2026 |
| 63 | XTX Topco Ltd | 32,825 | -74,754 (-69.49%) | $0 M | Nov 16, 2026 |
| 64 | Birchview Capital, LP | 30,000 | -41,218 (-57.88%) | $0 M | Nov 13, 2026 |
| 65 | Bank Of America Corp /de/ | 29,818 | +4,538 (+17.95%) | $0 M | Nov 16, 2026 |
| 66 | State Street Corp | 21,800 | New | $0 M | Nov 12, 2026 |
| 67 | Virtu Financial LLC | 18,022 | -7,619 (-29.71%) | $0 M | Nov 17, 2026 |
| 68 | Geode Capital Management, LLC | 15,979 | -13,559 (-45.90%) | $0 M | Nov 6, 2026 |
| 69 | Citigroup Inc | 15,027 | +1,810 (+13.69%) | $0 M | Nov 4, 2026 |
| 70 | Graham Capital Management, L.P. | 14,258 | New | $0 M | Nov 16, 2026 |
| 71 | Rhumbline Advisers | 12,088 | -1,727 (-12.50%) | $0 M | Nov 10, 2026 |
| 72 | GAMMA Investing LLC | 11,207 | +144 (+1.30%) | $0 M | Oct 8, 2026 |
| 73 | Wells Fargo & Company/mn | 9,100 | New | $0 M | Nov 16, 2026 |
| 74 | China Universal Asset Management Co., Ltd. | 8,572 | +1,097 (+14.68%) | $0 M | Oct 28, 2026 |
| 75 | PNC Financial Services Group, Inc. | 4,761 | New | $0 M | Nov 6, 2026 |
| 76 | National Bank Of Canada /fi/ | 4,001 | New | $0 M | Nov 16, 2026 |
| 77 | FNY Investment Advisers, LLC | 4,000 | New | $0 M | Oct 16, 2026 |
| 78 | Jpmorgan Chase & Co | 3,649 | -214 (-5.54%) | $0 M | Nov 12, 2026 |
| 79 | Tower Research Capital LLC (TRC) | 3,060 | +1,421 (+86.70%) | $0 M | Nov 16, 2026 |
| 80 | Jones Financial Companies Lllp | 2,500 | 0 (0.00%) | $0 M | Nov 13, 2026 |
| 81 | Mirae Asset Global Investments Co., Ltd. | 2,401 | +300 (+14.28%) | $0 M | Oct 29, 2026 |
| 82 | Parallel Advisors, LLC | 1,906 | +606 (+46.62%) | $0 M | Nov 3, 2026 |
| 83 | GF Fund Management Co. LTD. | 1,061 | +86 (+8.82%) | $0 M | Oct 26, 2026 |
| 84 | Rialto Wealth Management, LLC | 1,021 | 0 (0.00%) | $0 M | Nov 16, 2026 |
| 85 | Caitong International Asset Management Co., Ltd | 843 | +802 (+1956.10%) | $0 M | Oct 29, 2026 |
| 86 | Steward Partners Investment Advisory, LLC | 144 | +44 (+44.00%) | $0 M | Nov 13, 2026 |
| 87 | Assetmark, Inc | 118 | New | $0 M | Oct 21, 2026 |
| 88 | Nuveen, LLC | 114 | New | $0 M | Nov 10, 2026 |
| 89 | Osaic Holdings, Inc. | 100 | New | $0 M | Nov 12, 2026 |
| 90 | SBI Securities Co., Ltd. | 48 | +20 (+71.43%) | $0 M | Oct 22, 2026 |
| 91 | Rockefeller Capital Management L.P. | 45 | 0 (0.00%) | $0 M | Nov 13, 2026 |
| 92 | Nisa Investment Advisors, LLC | 18 | New | $0 M | Oct 20, 2026 |
Superinvestors holding Silence Therapeutics PLC
1 of the well-known investors value.today follows, from their newest Form 13F.
- Soros Fund Management · Soros Fund Management$1 Mnew · Sep 30, 2026
Mutual funds holding Silence Therapeutics PLC#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Fidelity Advisor Biotechnology FundFidelity Management & Research Company LLC | 482,088 | $5 M | — | 0.23% | new | Jul 31, 2026 |
| 🇺🇸 iShares Biotechnology ETFBlackRock Fund Advisors | 185,777 | $2 M | — | 0.02% | +7.2% | Jun 30, 2026 |
| 🇺🇸 Alger Small Cap Growth FundFred Alger Management, LLC | 105,679 | $1 M | — | 0.54% | new | Jul 31, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 29,538 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 State Street SPDR S&P International Small Cap ETFSSGA Funds Management, Inc. | 9,532 | $0 M | — | 0.01% | +1.0% | Jun 30, 2026 |
| 🇺🇸 Steward Values Enhanced International FundCrossmark Global Investments | 5,800 | $0 M | — | 0.02% | no change | Jul 31, 2026 |
| 🇺🇸 ActivePassive International Equity ETFTrust for Professional Managers | 8,695 | $0 M | — | <0.01% | new | May 31, 2026 |
| 🇺🇸 Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Advisors LLC | 1,000 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC | 24 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 9 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
How Silence Therapeutics PLC compares in Biotechnology
- Revenue$14 M · higher than 47% of 647
- Net margin-328.6% · higher than 18% of 408
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Silence Therapeutics PLC🇬🇧 | $189 M | — | -328.6% | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jul 30, 2023 (last known)
- Annual results:
- Dec-2021 ending year
- Balance sheet:
- Dec-2021 ending year
- Employees:
- As of December 31, 2025
- Profile updated:
- Nov 15, 2026
Figures from value.today research, Wikipedia, Wikidata, GLEIF register.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Silence Therapeutics PLC? Verify and update this profile — free
Show Silence Therapeutics PLC's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.